The equity investment is tied to an oncology research and licensing agreement covering IntraGel’s...
health
EIT Pharma has raised $35 million in a Series A led by Propel Bio...
The Zurich biotechnology startup is developing a multi-target pan-amyloid therapeutic for Alzheimer’s disease, with...
